Yahoo! Finance Search - Finance Home - Yahoo! - Help

Tuesday, February 21 2017 3:37pm ET - U.S. Markets close in 23 minutes.
Industry Center - Drug Manufacturers - Major
Industry Center > Drug Manufacturers - Major > News
More On This Industry
· Summary
News
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
· REIT - Retail
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
 
Drug Manufacturers - Major News
Latest News
Tuesday, Feb 21, 2017
·Bristol-Myers announces $2 bln accelerated share buyback; adds former Bausch & Lomb CFO, others to board
at MarketWatch - 14 minutes ago
·Assembly Biosciences Announces the Closing and Early Termination of Hart-Scott-Rodino Waiting Period for License of Microbiome Gastrointestinal Development Programs to Allergan
GlobeNewswire - 32 minutes ago
·Bristol-Myers Squibb Appoints Three New Independent Directors
Business Wire - 38 minutes ago
·First Comprehensive Pediatric Hematology-Oncology Initiative Launched in Africa
Business Wire - Tue 3:00 am ET
Monday, Feb 20, 2017
·These Prescription Products Matter to Sanofi’s Growth
- Mon 10:37 am ET
·Sanofi’s Unique Foothold in Diabetes and Cardiovascular
- Mon 9:06 am ET
·[$$] Alzheimer's: Pharma's Great White Whale Is Still Worth Hunting
at The Wall Street Journal Online - Mon 9:03 am ET
·Enbrel Strengthens Its Position in Rheumatology and Dermatology Segments
- Mon 7:36 am ET
·If You Want Yield, Look to the UK
- Sun 10:14 pm ET
Saturday, Feb 18, 2017
·Roche says Phase II trial supports twin treatment for kidney cancer
Reuters - Sat Feb 18
·Momenta Pharma shares halted as drug application hits speed bump
at MarketWatch - Fri Feb 17
·Inside Sanofi’s Revenues in 4Q16
- Fri Feb 17
Friday, Feb 17, 2017
·​Ethicon to acquire competitor
at bizjournals.com - Fri Feb 17
·New Data in Crohn’s Disease Patients Shows Similar Efficacy and Safety Profiles for INFLECTRA® and REMICADE®a
Business Wire - Fri Feb 17
·Immune Pharmaceuticals Announces the launch of REMAIN ™ , an international Overall Survival study with Ceplene® and low dose Proleukin® in REmission MAINtenance in Acute Myeloid Leukemia
PR Newswire - Fri Feb 17
·Blog Coverage Ionis Pharma Closed on its Collaboration Agreement with Novartis Following Clearance under the Hart-Scott-Rodino Antitrust Improvements Act
- Fri Feb 17
·AstraZeneca Stock Rises On Successful Breast Cancer Drug Trial
at TheStreet.com - Fri Feb 17
·AbbVie Announces $5 Billion Increase to Stock Repurchase Program
PR Newswire - Fri Feb 17
·Prolia Expected to Be a Significant Growth Driver for Amgen in 2017
- Fri Feb 17
·LYNPARZA™ (olaparib) Meets Primary Endpoint in Phase III Trial in BRCA-Mutated Metastatic Breast Cancer
Business Wire - Fri Feb 17
More Latest News...
  

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drug Manufacturers - Major Headlines
More Finance RSS Feeds


Copyright © 2017 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2017 Morningstar, Inc. All Rights Reserved. Company information © 2017 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2017, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?